# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Antimicrobial resistance

Extent: E+W+S+N.I.

The results of antimicrobial susceptibility tests must be reported according to the methods and criteria agreed between ECDC and Member States as specified by ECDC's European Antimicrobial Resistance Surveillance Network (EARS-Net), and in particular:
for Staphylococcus aureus: susceptibility to meticillin and other anti-staphylococcal beta-lactams;
for Enterococcus faecium and Enterococcus faecalis: susceptibility to glycopeptides;
for Klebsiella pneumoniae and Escherichia coli: susceptibility to carbapenems, and susceptibility to colistin in carbapenem-resistant isolates;
for Pseudomonas aeruginosa and Acinetobacter species: susceptibility to carbapenems.

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/4/division/4.2/division/5 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-4/division-4.2/division-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.